# FDA 483 - Douglas Glenn Young, M.D. - November 20, 2023

Source: https://www.keypedia.com/records/483/douglas-glenn-young-md/0ce42acc-542f-4e2a-9181-d7a35da2305b

> FDA 483 for Douglas Glenn Young, M.D. on November 20, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Douglas Glenn Young, M.D.
- Inspection Date: 2023-11-20
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: An FDA inspection of Clinical Investigator Douglas Glenn Young in Sacramento, CA, revealed significant deviations from the investigational plan. The inspection found that staff were not properly trained prior to performing clinical trial activities, leading to incorrect dosing of investigational drugs for multiple subjects. These findings indicate a failure to ensure proper conduct and oversight of the clinical study.

## Related Officers

- [Linh Tu](https://www.keypedia.com/people/linh-tu/142c94dc-9538-4c52-9a5f-be27fc7c4f4b)

Company: https://www.keypedia.com/companies/douglas-glenn-young-md/8df28cec-c379-4bbf-a055-6f2996fa1da3

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b